Table 2.
Cohort | 28 day mortality | 3 month mortality | 1 year mortality | 28 day readmission | 3 month readmission | 1 year readmission |
---|---|---|---|---|---|---|
ADHERE | 0.758 (0.671–0.845) | 0.768 (0.689–0.847) | 0.757 (0.681–0.833) | 0.609 (0.558–0.659) | 0.599 (0.570–0.628) | 0.568 (0.542–0.593) |
GWTG‐HF | 0.767 (0.677–0.856) | 0.772 (0.691–0.854) | 0.762 (0.684–0.840) | 0.640 (0.594–0.696) | 0.608 (0.579–0.637) | 0.569 (0.543–0.594) |
ASCEND | 0.833 (0.775–0.891) | 0.827 (0.771–0.884) | 0.802 (0.742–0.862) | 0.655 (0.609–0.701) | 0.614 (0.586–0.643) | 0.580 (0.555–0.605) |
GISSI‐HF | 0.839 (0.781–0.896) | 0.831 (0.777–0.885) | 0.822 (0.768–0.876) | 0.661 (0.616–0.705) | 0.623 (0.594–0.651) | 0.598 (0.573–0.622) |
SHFM | 0.794 (0.724–0.864) | 0.790 (0.725–0.856) | 0.787 (0.725–0.849) | 0.680 (0.637–0.723) | 0.636 (0.608–0.663) | 0.608 (0.583–0.633) |
MAGGIC‐HF | 0.850 (0.786–0.915) | 0.836 (0.774–0.897) | 0.819 (0.756–0.883) | 0.660 (0.616–0.705) | 0.623 (0.595–0.651) | 0.602 (0.577–0.627) |
BCN‐Bio‐HF | 0.838 (0.785–0.891) | 0.828 (0.777–0.879) | 0.812 (0.758–0.865) | 0.680 (0.636–0.724) | 0.620 (0.593–0.648) | 0.598 (0.573–0.623) |
ADHERE, the Acute Decompensated Heart Failure National Registry model; ASCEND, Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure risk scores; AUC, area under the receiver operating characteristic curve; BCN‐Bio‐HF, Barcelona Bio‐Heart Failure risk calculator; GISSI‐HF, Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico‐Heart Failure; GWTG‐HF, Get With the Guidelines‐Heart Failure programme; MAGGIC‐HF, Meta‐Analysis Global Group in Chronic Heart Failure risk score; SHFM, Seattle Heart Failure Model.